Sponsors & Exhibition

industry prospectus

You can find all the info you want about our sponsor and exhibition options in our Industry Prospectus, available for download.

Download Industry Prospectus


MedTech compliance

We are pleased to inform you that our congress has been found COMPLIANT with the MedTech Europe Code of Ethical Business Practice.


Educational Partners

Platinum Level

Aerie Pharmaceuticals

Aerie

Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. In the U.S., Aerie developed and markets Rhopressa® (netarsudil ophthalmic solution) 0.02%, a Rho kinase (ROCK) inhibitor, and the fixed-dose combination Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. Aerie has established development operations in Europe and Japan and a global manufacturing facility in Ireland. Aerie is expanding its ophthalmic pipeline with two clinical-stage retina programs in the U.S. and exploration of its proprietary library of small-molecule multi-kinase inhibitors.Visit Aerie online

Aerie is providing an unrestricted education grant to the Advances in Glaucoma Research and Clinical Science Meeting 2019.


Bronze Level

Santen

Santen
Santen offers innovative ophthalmic products and a clear vision for life to people throughout the world.
Santen is providing an unrestricted education grant to the Advances in Glaucoma Research and Clinical Science Meeting 2019.


Exhibitors

Aerie
Aerie Pharmaceuticals – Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. In the U.S., Aerie developed and markets Rhopressa® (netarsudil ophthalmic solution) 0.02%, a Rho kinase (ROCK) inhibitor, and the fixed-dose combination Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. Aerie has established development operations in Europe and Japan and a global manufacturing facility in Ireland. Aerie is expanding its ophthalmic pipeline with two clinical-stage retina programs in the U.S. and exploration of its proprietary library of small-molecule multi-kinase inhibitors.Visit Aerie online


Kugler Publications (est. 1974) is an independent publishing company specialized in Oto-Rhino-Laryngology, Ophthalmology, and related fields. Kugler has built a rich experience and solid reputation in publishing books, journals, proceedings and other publications; both in print and electronic. Here at Kugler Publications we aim to keep Simon Kugler’s warm personal touch, and way of doing business based on trust, friendship and long lasting relations incorporated into our everyday company culture. Drop by our booth to browse our publications or discuss your publications ideas.


VISU farma
VISUfarma is a pan-European ophthalmic pharmaceutical company with a clear mission: to bring quality products and global therapeutic innovation to European eye health. Formed in 2016, we are an ambitious and fast growing ophthalmology company, commercialising a broad portfolio of pharmaceutical products and medical devices across Europe and in 20+ countries worldwide through exclusive distributors. We offer a complete portfolio of products in the areas of dry eye, eyelid hygiene, meibomian gland dysfunction (MGD), blepharitis & demodex management, retinal health & food supplements and glaucoma.

Kugler Publications

Kugler Publications

Postal address:
P.O. Box 20538
1001 NM Amsterdam
The Netherlands
Tel: +31 20 68 45 700
www.kuglerpublications.com
info@kuglerpublications.com